Ammonia toxicity: from head to toe?
dc.contributor.author | Dasarathy, Srinivasan | |
dc.contributor.author | Mookerjee, Rajeshwar P. | |
dc.contributor.author | Rackayova, Veronika | |
dc.contributor.author | Rangroo Thrane, Vinita | |
dc.contributor.author | Vairappan, Balasubramaniyan | |
dc.contributor.author | Ott, Peter | |
dc.contributor.author | Rose, Christopher | |
dc.date.accessioned | 2020-01-03T13:43:41Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2020-01-03T13:43:41Z | |
dc.date.issued | 2016-12 | |
dc.identifier.uri | http://hdl.handle.net/1866/22930 | |
dc.publisher | Springer | fr |
dc.subject | Ammonia | fr |
dc.subject | Brain | fr |
dc.subject | Hepatic encephalopathy | fr |
dc.subject | Liver | fr |
dc.subject | Muscle | fr |
dc.subject | Toxicity | fr |
dc.title | Ammonia toxicity: from head to toe? | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de médecine | fr |
dc.identifier.doi | 10.1007/s11011-016-9938-3 | |
dcterms.abstract | Ammonia is diffused and transported across all plasma membranes. This entails that hyperammonemia leads to an increase in ammonia in all organs and tissues. It is known that the toxic ramifications of ammonia primarily touch the brain and cause neurological impairment. However, the deleterious effects of ammonia are not specific to the brain, as the direct effect of increased ammonia (change in pH, membrane potential, metabolism) can occur in any type of cell. Therefore, in the setting of chronic liver disease where multi-organ dysfunction is common, the role of ammonia, only as neurotoxin, is challenged. This review provides insights and evidence that increased ammonia can disturb many organ and cell types and hence lead to dysfunction. | fr |
dcterms.isPartOf | urn:ISSN:0885-7490 | fr |
dcterms.isPartOf | urn:ISSN:1573-7365 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | Dasarathy S, Mookerjee RP, Rackayova V, et al. Ammonia toxicity: from head to toe? Metab Brain Dis. 2017;32:529–538. doi:10.1007/s11011-016-9938-3 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Metabolic brain disease | |
oaire.citationVolume | 32 | |
oaire.citationIssue | 2 | |
oaire.citationStartPage | 529 | |
oaire.citationEndPage | 538 |
Fichier·s constituant ce document
Ce document figure dans la ou les collections suivantes
Ce document diffusé sur Papyrus est la propriété exclusive des titulaires des droits d'auteur et est protégé par la Loi sur le droit d'auteur (L.R.C. (1985), ch. C-42). Il peut être utilisé dans le cadre d'une utilisation équitable et non commerciale, à des fins d'étude privée ou de recherche, de critique ou de compte-rendu comme le prévoit la Loi. Pour toute autre utilisation, une autorisation écrite des titulaires des droits d'auteur sera nécessaire.